Business Description
Revolution Medicines Inc
NAICS : 325411
SIC : 2833
ISIN : US76155X1000
Share Class Description:
FRA:42Z: Ordinary SharesDescription
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 17.87 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | -0.15 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 28.77 | |||||
| Beneish M-Score | -15.52 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -49.3 | |||||
| 3-Year EBITDA Growth Rate | -27 | |||||
| 3-Year EPS without NRI Growth Rate | -24.3 | |||||
| 3-Year FCF Growth Rate | -19 | |||||
| 3-Year Book Growth Rate | 15.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate | -3.96 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 69.04 | |||||
| 9-Day RSI | 66.45 | |||||
| 14-Day RSI | 66.27 | |||||
| 6-1 Month Momentum % | 24.71 | |||||
| 12-1 Month Momentum % | 122.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 14.24 | |||||
| Quick Ratio | 14.24 | |||||
| Cash Ratio | 13.98 | |||||
| Days Sales Outstanding | 667.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -35.2 | |||||
| Shareholder Yield % | -0.24 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -88031.94 | |||||
| Net Margin % | -76423.32 | |||||
| FCF Margin % | -74306.76 | |||||
| ROE % | -37.43 | |||||
| ROA % | -33.26 | |||||
| ROIC % | -322.27 | |||||
| ROC (Joel Greenblatt) % | -640.1 | |||||
| ROCE % | -37.91 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 11716 | |||||
| PB Ratio | 6.27 | |||||
| Price-to-Tangible-Book | 6.58 | |||||
| EV-to-EBIT | -13.86 | |||||
| EV-to-Forward-EBIT | -11.05 | |||||
| EV-to-EBITDA | -14.12 | |||||
| EV-to-Forward-EBITDA | -11.27 | |||||
| EV-to-Revenue | 11309.32 | |||||
| EV-to-Forward-Revenue | 443.12 | |||||
| EV-to-FCF | -15.23 | |||||
| Price-to-Net-Current-Asset-Value | 7.11 | |||||
| Price-to-Net-Cash | 7.27 | |||||
| Earnings Yield (Greenblatt) % | -7.22 | |||||
| FCF Yield % | -5.59 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Revolution Medicines Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.68 | ||
| EPS (TTM) (€) | -3.353 | ||
| Beta | 1.82 | ||
| Volatility % | 37.68 | ||
| 14-Day RSI | 66.27 | ||
| 14-Day ATR (€) | 1.245974 | ||
| 20-Day SMA (€) | 53.345 | ||
| 12-1 Month Momentum % | 122.56 | ||
| 52-Week Range (€) | 19.9 - 56.5 | ||
| Shares Outstanding (Mil) | 168.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Revolution Medicines Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Revolution Medicines Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Revolution Medicines Inc Frequently Asked Questions
What is Revolution Medicines Inc(FRA:42Z)'s stock price today?
The current price of FRA:42Z is €55.00. The 52 week high of FRA:42Z is €56.50 and 52 week low is €19.90.
When is next earnings date of Revolution Medicines Inc(FRA:42Z)?
The next earnings date of Revolution Medicines Inc(FRA:42Z) is 2025-02-26 Est..
Does Revolution Medicines Inc(FRA:42Z) pay dividends? If so, how much?
Revolution Medicines Inc(FRA:42Z) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers